Menu

News & Events

                     

 


     30 October 2018

    TCTU attended the Annual NHS Research Scotland Conference on Tuesday 30 October in Perth. More info... 


     16 November 2018

    Sarah, Lewis and Chris will be attending the Scottish Society of Gastroenterology meeting on Friday 16 November. Lewis will give an oral presentation on the
    ADVANCE study. Sarah and Chris will present posters on ERAPID and SuperDot-C studies. 
More info...

 


     19 September 2018

    Sarah Inglis, Lewis Beer and Chris Byrne attended the 7th Annual International Symposium on Hepatitis Care in Substance Users in Portugal
     (http://www.inhsu2018.com/). Chris and Sarah presented posters. Andrew Radley presented preliminary findings of SuperDOT-C.

  • Poster: Pharmacological monitoring of participants undergoing DAA treatment for Hepatitis C infection in NHS Tayside: Concomitant medications of people who inject drugs participating in the SuperDot-C trial
  • Poster: Towards the Microelimination of Hepatitis C Virus in Tayside, Scotland, UK
  • Poster: Preliminary analysis of the superdot-c study: a cluster randomised controlled trial of pharmacy led versus conventional treatment for hcv positive patients receiving daily opiod substitution therapy within NHS Scotland

 


 28 August 2017

‘Gold standard’ recognition for Tayside Clinical Trials Unit: Tayside Clinical Trials Unit (TCTU), a joint initiative between the University of Dundee and NHS Tayside, has been recognised for the 'gold standard' of its clinical research. The TCTU has retained full registration status by the UK Clinical Research Collaboration, the national body overseeing clinical trial units in this country. To receive full registration a unit such as TCTU has to demonstrate to an international panel of experts that it can coordinate multi-centre clinical trials and deliver them to the highest quality standards as well as publish the results in quality journals. More info..